The ureteral stents market accounts for the largest share amongst all segments within the global non vascular stents market with approximately 49.7%.

San Mateo, CA -- (ReleaseWire) -- 03/10/2014 -- Persistence Market Research is pleased to announce the addition of a new report to its repository on "Non Vascular Stents (Gastrointestinal (Colorectal, Esophageal, Duodenal), Urological (Ureteral, Prostatic), Others (Pulmonary (Tracheo-Bronchial) & Biliary Stents), Drug-Eluting, Bare Metal & Bioabsorbable Stents) Market Assessment Report - Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2014-2020", according to which the global non vascular stents market was worth $518.7 million in 2013 and is expected to reach $741.7 million in 2020, growing at a CAGR of 5.3% from 2014 to 2020.

Initially used only in the vascular system and for cardiology purposes, stents have evolved since their introduction. This new non vascular stents have been now used in the gastrointestinal as well as the biliary and urinary tracts and in the tracheo-bronchial or pulmonary tree. The market for non vascular stents is observed to be driven by increasing incidence of GI tract cancers and tumors, prostate cancers, benign prostatic hyperplasia, kidney and gall stones causing urinary and colorectal blockages and strictures. Major restraints are technological challenges associated with perforations, failed release of stent from catheters, breakage of stent material and others.

In terms of application areas for the non vascular stents market, the market for urological stents was estimated to be the highest in 2013. Urological stents have been used over the past 2 decades to relieve blocked urinary tract and the highly common occurring phenomenon of kidney stones from the bladder. Many people have recurring kidney stones that eventually require surgical intervention such as insertion of stent to treat hydronephrosis or swelling of the ureter. Furthermore, the ureteral stents market accounts for the largest share amongst all segments within the global NV stents market with approximately 49.7%. Major indications for placing ureteral stents are malignant ureteral obstruction, kidney stones and constrictures of other kinds that require interventional methods to treat. The gastrointestinal NV stents (colorectal, esophageal and duodenal stents) market comes second with a market share of over 15% of the overall non vascular stents market. A major driver for this market share has been the increasing use of GI stents in the past few years particularly due to the rising incidence of colorectal and esophageal cancers worldwide.

Please click here to view the report contents in detail...

In the non vascular stents technology market, the market for bare metal stents (BMS) constituted the largest share of the total non vascular stents market at 87% in 2013. Major drivers for this market are the excellent biocompatibility with human organs, high elasticity and strength. However, some challenges associated with BMS are greater chances of granulations, blood clotting, mucus trapping and difficult removal (particularly in case of GI stents). That being said, the market is expected to be challenged by the rising bioabsorbable stents segment and forecasted drug-eluting stents that may soon overcome these difficulties. The drug-eluting NV stents market is expected to grow at a CAGR of more than 14% by 2020.

Geographically, North America was estimated to be the largest market with a share of 33%. Presence of companies such as Boston Scientific, Cook Medical, Allium and Merit Medical has prevented other regions to compete with North America. This is followed by Europe with a key player - Ella-CS contributing to the market from the European region and is currently a leader in bioabsorbable non vascular stents. The Latin America region has observed a significant increase in cases of prostatic cancers and benign prostatic hyperplasia and thus accounted for a share of 12.7% of the global market in 2013. Asian countries particularly Korea and Japan are strong markets with presence of companies such as Taewoong Medical, Stentech, Micro-Tech (Nanjing) Ltd and MI Tech. The Asia-Pacific market is expected to grow at the highest CAGR from 2014 to 2020.

Boston Scientific dominated the non vascular stents market in 2013 mainly due to the high demand of this currently niche product segment, where Boston Scientific has a considerable product portfolio. Other key players in the market include Ella-CS, Merit Medical, Cook Medical, among many other players.

Please click here to view the report contents in detail...

The global non vascular stents market is segmented as follows:
Global Non Vascular (NV) Stents Market, by Application Area
- Gastrointestinal NV Stents
Colorectal NV Stents
Esophageal NV Stents
Duodenal NV Stents
- Urological NV Stents
Ureteral NV Stents
Prostatic Stents
- Other NV Stents
Pulmonary (Tracheo-Bronchial) NV Stents
Biliary NV Stents

Global Non Vascular (NV) Stents Market, by Technologies
- Drug-Eluting NV Stents
- Bare Metal NV Stents
- Bioabsorbable NV Stents

Global Non Vascular (NV) Stents Market, by Geography
- North America
- Latin America
- Europe
- Asia-Pacific
- Middle-East
- Africa
- Rest of the World (RoW)

Please click here to view other medical device related reports..

About Persistence Market Research
Persistence Market Research is a specialized team of analysts and consultants in healthcare domain. Our business intelligence and market research capabilities span over multiple sub-industries under healthcare such as Medical Device, Healthcare-IT, Biotechnology and Pharmaceuticals.

Our understanding about the market persuades us to share the right information with the right reader and save time on decision making. In today's competitive market world, the decision making of our clients does not merely depend upon their wishes but also on technological advancements and what their competitors are doing or plan to do. This is where we come in existence, with extensive healthcare domain knowledge and statistical analysis background helping our clients with quick and accurate market information.

Contact
Mr. Reilly Jay
845 N Humboldt Street,
Suite 1015,
San Mateo, CA 94401
United States
Tel: +1-650-242-4491
US/Canada Toll Free Number: 1-877-667-4748
E-mails:
jay@persistencemarketresearch.com
sales@persistencemarketresearch.com
Website: http://www.persistencemarketresearch.com

For more information on this press release visit: http://www.releasewire.com/press-releases/non-vascular-stents-market-expected-to-reach-7417-million-in-2020-growing-at-a-cagr-of-53-from-2014-to-2020-473687.htm

Persistence Market Research announces the launch of its market assessment report on “External Beam Radiation Therapy Devices (CyberKnife, TomoTherapy, Gamma Knife, High-Energy Linear Accelerators (LINACs), Proton Therapy, Prostate Cancer, Intensity Modulated Radiation Therapy (IMRT), Image Guided Radio Therapy (IGRT), Stereotactic, 3-D Conformal Radiotherapy (3-D CRT), Volumetric Modulated Arc Therapy (VMAT), Adaptive Radiation Therapy (ART) Market Assessment Report - Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2013-2017”

San Mateo, CA -- (ReleaseWire) -- 01/27/2014 -- The global external beam radiation therapy devices market was worth $3,308.6 million in 2012 and is expected to reach $4,304.9 million in 2017, growing at a CAGR of 5.4% from 2013 to 2017.

External beam radiotherapy market is primarily driven by electron emitting high energy linear accelerators, followed by compact advanced radiotherapy systems and proton therapy systems. In comprehensive compact advanced radiotherapy market, Gamma Knife holds the major share presently compared to CyberKnife and TomoTherapy devices. As accuracy is the main concern for the intracranial treatment to protect sensitive neighbouring tissues, Gamma Knife was always the first choice of the physician for its huge popularity. Proton machine market is highly dominated by huge cyclotron machines. The rest of the market is occupied by synchrotron machines. Comprehensiveness of entire cyclotron system is the major driver for this market.

A LINAC or linear accelerator is the most important component of external beam therapy devices and perpetual variations and development in their characteristics such as electron-emitting high energy machines and proton therapy machines have rendered scope for the evolution of different types of external beam therapy. Further miniaturization of devices has led to introduction of radiosurgery systems such as Gamma Knife, TomoTherapy and CyberKnife. Radiosurgery systems though being a small contributor, they are the most technologically advanced area in the external beam therapy systems market. Synchrotron and cyclotron systems have a wide range of applications and high contribution to the field of radiation oncology.

Please click here to view the report contents in detail.

External beam radiation therapy forms the major part of all radiotherapy procedures, being given principal importance over the other two technologies namely internal beam radiation or brachytherapy and systemic radiation therapy. Continuous technical upheaval combined with efficient reimbursement support from developed countries of North America and Europe are the major reasons for this huge external beam radiation therapy market growth.

In terms of technology, IMRT procedure has become a standard for treatment in prostate cancer, CNS and head and neck cancer due to its multiple targets, multiple critical avoidance and differential weightages to critical tissues. The considerable penetration of IGRT and other advanced technologies that significantly answer the growing demand of obtaining real time pictures during treatment procedures for better outcomes has marred the market growth of IMRT. However, healthy reimbursement policies and governmental support will continue to drive this market significantly in the coming years.

Rapid introduction of new therapeutic technologies of radiotherapy have made this market dynamic in nature. Over the period, the old therapeutic technologies used in treatment for cancer are perpetually being replaced with new technological advancements. The well established markets of North America and Europe are already employing different therapeutic techniques and thereby overtaking the outgoing technologies. Furthermore, developing markets of Asia-Pacific, Latin America and Middle East have begun their efforts to incorporate the latest therapeutic modalities in their healthcare system.

Please click here to view the report contents in detail.

Huge market sales of conventional IMRT and IGRT external beam radiation devices has made Varian lead the global external radiation therapy market with a market share of over 50%, and in turn, the leader in global overall radiotherapy market.
Other prominent players include Elekta, Accuray Inc., IBA S.A among others.

The global external beam radiation therapy devices market is segmented as follows:

Global External Beam Radiation Therapy Devices Market, by Products
-CyberKnife
-TomoTherapy
-Gamma Knife
-High-energy Linear Accelerators (LINACs)

Global External Beam Radiation Therapy Devices Market, by Applications
-Prostate Cancer
-Colorectal Cancer
-Breast Cancer
-Lung Cancer
-Head & Neck Cancer
-Spine Cancer
-Neurosurgery and Brain Cancer

Global External Beam Radiation Therapy Devices Market, by Technology
-Intensity Modulated Radiation Therapy (IMRT)
-Image Guided Radio Therapy (IGRT)
-Tomotherapy
-Stereotactic Technology
-3-D Conformal Radiotherapy (3-D CRT)
-Proton Therapy
-Volumetric Modulated Arc Therapy (VMAT)
-Adaptive Radiation Therapy (ART)

Global External Beam Radiation Therapy Devices Market, by Geography
-North America
-Europe
-Asia
-Rest of the World (RoW)

Please click here to view other medical device related reports.

About Persistence Market Research
Persistence Market Research is a specialized team of analysts and consultants in healthcare domain. Our business intelligence and market research capabilities span over multiple sub-industries under healthcare such as Medical Device, Healthcare-IT, Biotechnology and Pharmaceuticals.

Our understanding about the market persuades us to share the right information with the right reader and save time on decision making. In today's competitive market world, the decision making of our clients does not merely depend upon their wishes but also on technological advancements and what their competitors are doing or plan to do. This is where we come in existence, with extensive healthcare domain knowledge and statistical analysis background helping our clients with quick and accurate market information.

Contact
Mr. Reilly Jay
845 N Humboldt Street,
Suite 1015,
San Mateo, CA 94401
United States
Tel: +1-650-242-4491
US/Canada Toll Free Number: 1-877-667-4748
E-mails:
jay@persistencemarketresearch.com
sales@persistencemarketresearch.com
Website: http://www.persistencemarketresearch.com

For more information on this press release visit: http://www.releasewire.com/press-releases/external-beam-radiation-therapy-devices-market-is-expected-to-reach-43-billion-in-2017-growing-at-a-cagr-of-54-from-2013-to-2017-446738.htm